Topics

Frequency's regenerative hearing loss drug gains fast track status

06:35 EDT 11 Oct 2019 | SmartBrief

The FDA granted fast track designation to Frequency Therapeutics' investigational candidate FX-322, a regenerative drug for h -More

Original Article: Frequency's regenerative hearing loss drug gains fast track status

NEXT ARTICLE

More From BioPortfolio on "Frequency's regenerative hearing loss drug gains fast track status"

Quick Search

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...